{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:55:40Z","timestamp":1781013340389,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-024-05931-y","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T10:02:38Z","timestamp":1725444158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The role of local ablative therapy in patients with advanced invasive mucinous adenocarcinoma of the lung"],"prefix":"10.1007","volume":"150","author":[{"given":"Soo Han","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayoung","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonggeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Yeong","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Su","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoseok","family":"I","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong Dae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ki","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Seop","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,4]]},"reference":[{"key":"5931_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.humpath.2017.08.002","volume":"71","author":"JM Boland","year":"2018","unstructured":"Boland JM, Maleszewski JJ, Wampfler JA, Voss JS, Kipp BR, Yang P, Yi ES (2018) Pulmonary invasive mucinous adenocarcinoma and mixed invasive mucinous\/nonmucinous adenocarcinoma-a clinicopathological and molecular genetic study with survival analysis. Hum Pathol 71:8\u201319. https:\/\/doi.org\/10.1016\/j.humpath.2017.08.002","journal-title":"Hum Pathol"},{"key":"5931_CR3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.21037\/tlcr.2017.06.10","volume":"6","author":"YJ Cha","year":"2017","unstructured":"Cha YJ, Shim HS (2017) Biology of invasive mucinous adenocarcinoma of the lung. Transl Lung Cancer Res 6:508\u2013512. https:\/\/doi.org\/10.21037\/tlcr.2017.06.10","journal-title":"Transl Lung Cancer Res"},{"key":"5931_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.lungcan.2016.11.004","volume":"102","author":"YJ Cha","year":"2016","unstructured":"Cha YJ, Kim HR, Lee HJ, Cho BC, Shim HS (2016) Clinical course of stage IV invasive mucinous adenocarcinoma of the lung. Lung Cancer 102:82\u201388. https:\/\/doi.org\/10.1016\/j.lungcan.2016.11.004","journal-title":"Lung Cancer"},{"key":"5931_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.trsl.2020.10.005","volume":"229","author":"AK Dilly","year":"2021","unstructured":"Dilly AK, Honick BD, Frederick R, Elapavaluru A, Velankar S, Makala H et al (2021) Improved chemosensitivity following mucolytic therapy in patient-derived models of mucinous appendix cancer. Transl Res 229:100\u2013114. https:\/\/doi.org\/10.1016\/j.trsl.2020.10.005","journal-title":"Transl Res"},{"key":"5931_CR5","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1200\/jco.22.01989","volume":"41","author":"MC Garassino","year":"2023","unstructured":"Garassino MC, Gadgeel S, Speranza G, Felip E, Esteban E, D\u00f3mine M et al (2023) Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-small-cell Lung Cancer: 5-Year outcomes from the phase 3 KEYNOTE-189 study. J Clin Oncol 41:1992\u20131998. https:\/\/doi.org\/10.1200\/jco.22.01989","journal-title":"J Clin Oncol"},{"key":"5931_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE et al (2016) The IASLC Lung Cancer Staging Project: proposals for revision of the TNM Stage groupings in the Forthcoming (Eighth) Edition of the TNM classification for Lung Cancer. J Thorac Oncol 11:39\u201351. https:\/\/doi.org\/10.1016\/j.jtho.2015.09.009","journal-title":"J Thorac Oncol"},{"key":"5931_CR7","doi-asserted-by":"publisher","unstructured":"Gow CH, Hsieh MS, Liu YN, Lee YH, Shih JY (2021) Clinicopathological features and survival outcomes of primary pulmonary invasive mucinous adenocarcinoma. Cancers (Basel) 13. https:\/\/doi.org\/10.3390\/cancers13164103","DOI":"10.3390\/cancers13164103"},{"key":"5931_CR8","doi-asserted-by":"publisher","first-page":"462","DOI":"10.15252\/emmm.201606711","volume":"9","author":"M Guo","year":"2017","unstructured":"Guo M, Tomoshige K, Meister M, Muley T, Fukazawa T, Tsuchiya T et al (2017) Gene signature driving invasive mucinous adenocarcinoma of the lung. EMBO Mol Med 9:462\u2013481. https:\/\/doi.org\/10.15252\/emmm.201606711","journal-title":"EMBO Mol Med"},{"key":"5931_CR9","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1097\/JTO.0b013e3181e2a2bc","volume":"5","author":"A Hata","year":"2010","unstructured":"Hata A, Katakami N, Fujita S, Kaji R, Imai Y, Takahashi Y, Nishimura T, Tomii K, Ishihara K (2010) Frequency of EGFR and KRAS mutations in Japanese patients with lung adenocarcinoma with features of the mucinous subtype of bronchioloalveolar carcinoma. J Thorac Oncol 5:1197\u20131200. https:\/\/doi.org\/10.1097\/JTO.0b013e3181e2a2bc","journal-title":"J Thorac Oncol"},{"key":"5931_CR10","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/ejcts\/ezv249","volume":"49","author":"T Hishida","year":"2016","unstructured":"Hishida T, Yoshida J, Aokage K, Nagai K, Tsuboi M (2016) Postoperative oligo-recurrence of non-small-cell lung cancer: clinical features and survival\u2020. Eur J Cardiothorac Surg 49:847\u2013853. https:\/\/doi.org\/10.1093\/ejcts\/ezv249","journal-title":"Eur J Cardiothorac Surg"},{"key":"5931_CR11","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/j.humpath.2013.05.026","volume":"44","author":"H Ichinokawa","year":"2013","unstructured":"Ichinokawa H, Ishii G, Nagai K, Kawase A, Yoshida J, Nishimura M et al (2013) Distinct clinicopathologic characteristics of lung mucinous adenocarcinoma with KRAS mutation. Hum Pathol 44:2636\u20132642. https:\/\/doi.org\/10.1016\/j.humpath.2013.05.026","journal-title":"Hum Pathol"},{"key":"5931_CR12","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1186\/s12885-021-08472-6","volume":"21","author":"YJ Jang","year":"2021","unstructured":"Jang YJ, Hyun DG, Choi CM, Lee DH, Kim SW, Yoon S, Kim WS, Ji W, Lee JC (2021) Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung. BMC Cancer 21:731. https:\/\/doi.org\/10.1186\/s12885-021-08472-6","journal-title":"BMC Cancer"},{"key":"5931_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/jto.0000000000000404","volume":"10","author":"I Lakshmanan","year":"2015","unstructured":"Lakshmanan I, Ponnusamy MP, Macha MA, Haridas D, Majhi PD, Kaur S, Jain M, Batra SK, Ganti AK (2015) Mucins in lung cancer: diagnostic, prognostic, and therapeutic implications. J Thorac Oncol 10:19\u201327. https:\/\/doi.org\/10.1097\/jto.0000000000000404","journal-title":"J Thorac Oncol"},{"key":"5931_CR14","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.jtho.2016.03.011","volume":"11","author":"HY Lee","year":"2016","unstructured":"Lee HY, Cha MJ, Lee KS, Lee HY, Kwon OJ, Choi JY et al (2016) Prognosis in Resected Invasive Mucinous adenocarcinomas of the lung: related factors and comparison with Resected Nonmucinous Adenocarcinomas. J Thorac Oncol 11:1064\u20131073. https:\/\/doi.org\/10.1016\/j.jtho.2016.03.011","journal-title":"J Thorac Oncol"},{"key":"5931_CR15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/jso.27165","volume":"127","author":"KJ Na","year":"2023","unstructured":"Na KJ, Kim YT (2023) The new oligometastatic disease state and associated therapies in non-small cell lung cancer: a narrative review. J Surg Oncol 127:282\u2013287. https:\/\/doi.org\/10.1002\/jso.27165","journal-title":"J Surg Oncol"},{"key":"5931_CR16","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s00432-020-03176-z","volume":"146","author":"Y Ni","year":"2020","unstructured":"Ni Y, Ye X, Yang X, Huang G, Li W, Wang J et al (2020) Microwave ablation for non-small cell lung cancer with synchronous solitary extracranial metastasis. J Cancer Res Clin Oncol 146:1361\u20131367. https:\/\/doi.org\/10.1007\/s00432-020-03176-z","journal-title":"J Cancer Res Clin Oncol"},{"key":"5931_CR17","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.ijrobp.2014.04.007","volume":"89","author":"RB Parikh","year":"2014","unstructured":"Parikh RB, Cronin AM, Kozono DE, Oxnard GR, Mak RH, Jackman DM et al (2014) Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer. Int J Radiat Oncol Biol Phys 89:880\u2013887. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.04.007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5931_CR18","doi-asserted-by":"publisher","first-page":"1070761","DOI":"10.3389\/fonc.2022.1070761","volume":"12","author":"L Peng","year":"2022","unstructured":"Peng L, Guo J, Kong L, Huang Y, Tang N, Zhang J et al (2022) Efficacy of immunotherapy in KRAS-mutant advanced NSCLC: a real-world study in a Chinese population. Front Oncol 12:1070761. https:\/\/doi.org\/10.3389\/fonc.2022.1070761","journal-title":"Front Oncol"},{"key":"5931_CR19","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1097\/js9.0000000000000339","volume":"109","author":"CH Rim","year":"2023","unstructured":"Rim CH, Cho WK, Park S, Yoon WS, Yang DS (2023) Role of local ablative treatment in oligometastatic non-small cell lung cancer: a meta-analysis. Int J Surg 109:1006\u20131014. https:\/\/doi.org\/10.1097\/js9.0000000000000339","journal-title":"Int J Surg"},{"key":"5931_CR20","doi-asserted-by":"publisher","unstructured":"Rosas D, Raez LE, Russo A, Rolfo C (2021) Neuregulin 1 Gene (NRG1). A potentially new Targetable Alteration for the treatment of Lung Cancer. Cancers (Basel) 13. https:\/\/doi.org\/10.3390\/cancers13205038","DOI":"10.3390\/cancers13205038"},{"key":"5931_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.lungcan.2020.05.030","volume":"146","author":"T Saito","year":"2020","unstructured":"Saito T, Tsuta K, Honda O, Ishida M, Yamaka R, Tanaka N et al (2020) Prognostic impact of mucin spread, tumor cell spread, and invasive size in invasive mucinous adenocarcinoma of the lung. Lung Cancer 146:50\u201357. https:\/\/doi.org\/10.1016\/j.lungcan.2020.05.030","journal-title":"Lung Cancer"},{"key":"5931_CR22","doi-asserted-by":"publisher","first-page":"101892","DOI":"10.1016\/j.ctrv.2019.101892","volume":"80","author":"DH Schanne","year":"2019","unstructured":"Schanne DH, Heitmann J, Guckenberger M, Andratschke NHJ (2019) Evolution of treatment strategies for oligometastatic NSCLC patients - a systematic review of the literature. Cancer Treat Rev 80:101892. https:\/\/doi.org\/10.1016\/j.ctrv.2019.101892","journal-title":"Cancer Treat Rev"},{"key":"5931_CR23","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1097\/jto.0000000000000579","volume":"10","author":"HS Shim","year":"2015","unstructured":"Shim HS, Kenudson M, Zheng Z, Liebers M, Cha YJ, Hoang Ho Q et al (2015) Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the lung. J Thorac Oncol 10:1156\u20131162. https:\/\/doi.org\/10.1097\/jto.0000000000000579","journal-title":"J Thorac Oncol"},{"key":"5931_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3892\/mco.2018.1651","volume":"9","author":"XW Sun","year":"2018","unstructured":"Sun XW, Ding YJ, Zhang YY, Chen PL, Yan YR, Shen JM, Li QY (2018) Favorable response to pemetrexed, cisplatin and bevacizumab in invasive mucinous adenocarcinoma: a case report and literature review. Mol Clin Oncol 9:192\u2013196. https:\/\/doi.org\/10.3892\/mco.2018.1651","journal-title":"Mol Clin Oncol"},{"key":"5931_CR26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","volume":"6","author":"WD Travis","year":"2011","unstructured":"Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y et al (2011) International association for the study of lung cancer\/american thoracic society\/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6:244\u2013285. https:\/\/doi.org\/10.1097\/JTO.0b013e318206a221","journal-title":"J Thorac Oncol"},{"key":"5931_CR25","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/jto.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB et al (2015) The 2015 World Health Organization Classification of Lung Tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 10:1243\u20131260. https:\/\/doi.org\/10.1097\/jto.0000000000000630","journal-title":"J Thorac Oncol"},{"key":"5931_CR27","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3348\/kjr.2020.0454","volume":"22","author":"T Wang","year":"2021","unstructured":"Wang T, Yang Y, Liu X, Deng J, Wu J, Hou L et al (2021) Primary invasive mucinous adenocarcinoma of the lung: prognostic value of CT imaging features combined with clinical factors. Korean J Radiol 22:652\u2013662. https:\/\/doi.org\/10.3348\/kjr.2020.0454","journal-title":"Korean J Radiol"},{"key":"5931_CR29","doi-asserted-by":"publisher","first-page":"683432","DOI":"10.3389\/fonc.2021.683432","volume":"11","author":"X Xu","year":"2021","unstructured":"Xu X, Li N, Wang D, Chen W, Fan Y (2021) Clinical relevance of PD-L1 expression and CD8\u2009+\u2009T cells\u2019 infiltration in patients with lung invasive mucinous adenocarcinoma. Front Oncol 11:683432. https:\/\/doi.org\/10.3389\/fonc.2021.683432","journal-title":"Front Oncol"},{"key":"5931_CR28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12032-023-02059-w","volume":"40","author":"M Xu","year":"2023","unstructured":"Xu M, Hao Y, Zhou H, Shi Z, Si J, Song Z (2023) Comparison of the immunotherapy efficacy between invasive mucinous and non-mucinous adenocarcinoma in advanced lung cancer patients with KRAS mutation: a retrospective study. Med Oncol 40:198. https:\/\/doi.org\/10.1007\/s12032-023-02059-w","journal-title":"Med Oncol"},{"key":"5931_CR30","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.trecan.2023.07.010","volume":"9","author":"MN Zeissig","year":"2023","unstructured":"Zeissig MN, Ashwood LM, Kondrashova O, Sutherland KD (2023) Next batter up! Targeting cancers with KRAS-G12D mutations. Trends Cancer 9:955\u2013967. https:\/\/doi.org\/10.1016\/j.trecan.2023.07.010","journal-title":"Trends Cancer"},{"key":"5931_CR31","doi-asserted-by":"publisher","first-page":"5899","DOI":"10.21037\/jtd-21-957","volume":"13","author":"C Zhang","year":"2021","unstructured":"Zhang C, Ma N, Zhang Q, Zheng K, Sun C, Tang X, Li X, Zhao J (2021) Evaluation of local aggressive lung therapy versus systemic therapy in oligometastatic non-small cell lung cancer: a systematic review and meta-analysis. J Thorac Dis 13:5899\u20135910. https:\/\/doi.org\/10.21037\/jtd-21-957","journal-title":"J Thorac Dis"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05931-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-024-05931-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05931-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T03:34:17Z","timestamp":1728444857000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-024-05931-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":31,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["5931"],"URL":"https:\/\/doi.org\/10.1007\/s00432-024-05931-y","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,4]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Pusan National University Hospital (IRB No. 2404-020-138). Written informed consent was not required for this study in accordance with national legislation and institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"409"}}